Cutera Announces the International Limited Commercial Release of AviClear® at IMCAS World Congress 2024

BRISBANE, Calif.–(BUSINESS WIRE)–CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announced the international limited commercial release of AviClear, the first energy-based device FDA-cleared for the long-term treatment of mild, moderate, and severe acne. AviClear received an enthusiastic reception at this year’s International Master Course on Aging…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks